Michael J Hallek

45PUBLICATIONS
268CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Social epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 26, 2026
Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.

|Jun 20, 2026
Ibrutinib for early-stage CLL: genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.

|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

|Apr 23, 2026
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.

|Apr 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesis.

|Apr 22, 2026
Unfinished business in chronic lymphocytic leukemia: translational and clinical priorities for a cure.

Pageof 8

Frequent Collaborators

9 joint publications

Florian Simon

9 joint publications

Sandra Robrecht

7 joint publications

Moritz Fürstenau

7 joint publications

Petra Langerbeins